Does the July share price for Trinity Biotech plc ( NASDAQ:TRIB ) reflect what it's really worth? Today, we will...
DUBLIN, Ireland, June 30, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced the Company’s results for the quarter ended March 31, 2022. Quarter 1 Results Total revenues for Q1, 2022 were $18.8m compared to $25.6m in Q1, 2021, a decrease of 26.6% as indicated below: 2021Quarter 12022Quarter 1Increase/(Decrease) $’000$’000%Point-of-Care1,8882,16414.6%Clinica
Conference Call Scheduled for June 30, 2022 at 11:00 am EASTERNDUBLIN, Ireland, June 29, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the first quarter fiscal year 2022 on Thursday, June 30, 2022. The Company has scheduled a conference call for that same day, Thursday June 30, 2022 at 11:00am ET (4:00pm BST) to discuss the results of